A bridge, not a destination: clarifying the role of polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory diffuse large B-cell lymphoma

The Korean Journal of Internal Medicine 2026 Open access

Read full text

Authors: Ho‐Young Yhim

DOI: 10.3904/kjim.2025.054

Cited by: 0

References: 5

Fields of Study & Subjects

Lymphoma Diagnosis and Treatment Chronic Lymphocytic Leukemia Research CNS Lymphoma Diagnosis and Treatment

References 5